Pharmacy Search
Vertice Login
Menu
close

Medmonitor

An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.
← Back to Medmonitor

Medication Type: Opioid Withdrawal

Lucemyra™ (lofexidine) tablets

Approval Date: Aug 2024

Note: First-Time Generic

Indicated for the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults

Medication Name

Approval Date

Category

Description

Lucemyra™ (lofexidine) tablets

Aug 2024

Indicated for the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults

Note: First-Time Generic
lockenvelopephone-handsetmagnifiermenucross-circle